XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Stock-Based Compensation - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended 71 Months Ended
Sep. 24, 2020
Mar. 31, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2022
Sep. 23, 2020
Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Payments to repurchase stock     $ 8,053,000 $ 4,297,000        
Award vesting period     4 years          
Volatility     46.88% 56.10%        
Expected term (in years)     5 years 7 months 24 days 5 years 8 months 1 day        
Expected dividend yield     0.00% 0.00%        
PSUs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     228,200 159,000        
Risk-free interest rate   1.60%            
Volatility   41.00%            
Expected term (in years)   3 years            
Expected dividend yield   0.00%            
S&P Biotechnology | PSUs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period   228,200            
S&P Biotechnology | PSUs | Chief Executive Officer                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average grant date fair value (in dollars per share)   $ 70.45            
S&P Biotechnology | PSUs | Other Executives                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average grant date fair value (in dollars per share)   $ 53.43            
March 2020 Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock repurchase program, authorized amount               $ 160,000,000
Accelerated share repurchases, authorized amount             $ 25,000,000  
Accelerated share repurchases, payment $ 25,000,000              
Accelerated share repurchases, shares received (in shares) 550,623              
Accelerated share repurchases, initial price paid per share (in dollars per share) $ 45.40              
Fair value adjustments related to derivative instruments         $ 3,000,000      
Share Repurchase Programs                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares of common stock repurchased (in shares)           4,278,831    
Payments to repurchase stock           $ 236,100,000